NutriBand (NTRB) Net Margin Growth (3y) (2021 - 2026)
NutriBand (NTRB) Net Margin Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -374.00 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -44.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | -389.00 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -13,815.00 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 7,793.00 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 9,934.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -11,156.00 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 31,387.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -5,319.00 |
| 10 | NutriBand | 57.74 Mn | 53.73 Mn | 196,801.00 | -7,370.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -7,370.00 |
| Jan 31, 2026 | 7,675.00 |
| Oct 31, 2025 | -94,497.00 |
| Jul 31, 2025 | -359,821.00 |
| Apr 30, 2025 | -6,372.00 |
| Jan 31, 2025 | -9,264.00 |
| Oct 31, 2024 | 41,380.00 |
| Jul 31, 2024 | -14,188.00 |
| Apr 30, 2024 | -39,193.00 |
| Jan 31, 2024 | 122,854.00 |
| Oct 31, 2023 | -40,049.00 |
| Jul 31, 2023 | 14,105.00 |
| Apr 30, 2023 | 13,246.00 |
| Jan 31, 2023 | -440,928.00 |
| Oct 31, 2022 | 73,829.00 |
| Jul 31, 2022 | 37,375.00 |
| Apr 30, 2022 | 15,180.00 |
| Oct 31, 2021 | 37,239.00 |